--- title: "Immunocore Holdings (IMCR) stock: news and investor profile" url: "https://aibio.space/companies/immunocore/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Immunocore Holdings plc (NASDAQ: IMCR), United Kingdom. The directory classifies it as Biotechnology." --- IMCR Immunocore Holdings plc NASDAQ · United Kingdom # Immunocore Holdings (IMCR) news Top story · Aug 6, 2026 · SEC filing 8-K ## [Immunocore reports results](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000020/imcr-20260806.htm) On August 6, 2026, Immunocore Holdings plc (the " Company ") issued a press release announcing its financial results for the second quarter ended June 30, 2026, as well as other recent corporate updates. Source: [8-K filed Aug 6, 2026 on SEC EDGAR](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000020/imcr-20260806.htm) ## Latest Immunocore Holdings news We have not published a story on Immunocore Holdings yet. When there is news, it will appear here. ## Immunocore Holdings at a glance - **Ticker**: IMCR - **Listing**: NASDAQ - **Country**: United Kingdom - **Cash, Jun 30, 2026**: $880.2 million ### Related companies - [Aptamer Group Plc](https://aibio.space/companies/aptamer/) LSE: APTA - [Vidac Pharma Holding Plc](https://aibio.space/companies/vidac-pharma/) XETR: T9G - [OptiBiotix Health](https://aibio.space/companies/optibiotix-health/) LSE: OPTI - [Thalia Therapeutics](https://aibio.space/companies/thalia-therapeutics/) LSE: THAT - [Genflow Biosciences Plc](https://aibio.space/companies/genflow-biosciences/) LSE: GENF - [Adaptimmune Therapeutics](https://aibio.space/companies/adaptimmune-therapeutics/) OTC: ADAPY - [Nuformix Plc](https://aibio.space/companies/nuformix/) LSE: NFX - [Oxford BioDynamics Plc](https://aibio.space/companies/oxford-biodynamics/) LSE: OBD ### Also on NASDAQ - [Relmada Therapeutics](https://aibio.space/companies/relmada-therapeutics/) RLMD - [Benitec Biopharma](https://aibio.space/companies/benitec-biopharma/) BNTC - [Kodiak Sciences](https://aibio.space/companies/kodiak-sciences/) KOD - [Rocket Pharmaceuticals](https://aibio.space/companies/rocket-pharmaceuticals/) RCKT - [TuHURA Biosciences](https://aibio.space/companies/tuhura-biosciences/) HURA - [Lexicon Pharmaceuticals](https://aibio.space/companies/lexicon-pharmaceuticals/) LXRX ## Immunocore Holdings annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$274.9 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | [$222.2 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | | Net income (loss) | [-$35.5 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | [-$51.1 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | | Cash from operations | [-$10.7 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | [$26.1 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | | Cash and equivalents | [$467.7 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000022/) | [$455.7 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | | Short-term investments | [$396.4 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000022/) | [$364.6 million](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000005/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $484.9 million, plus short-term investments of $395.3 million, $880.2 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Immunocore Holdings What is the ticker symbol of Immunocore Holdings? Immunocore Holdings plc trades under the ticker IMCR on NASDAQ. Where is Immunocore Holdings listed? Immunocore Holdings plc is listed on NASDAQ. What is the SEC CIK of Immunocore Holdings? The SEC Central Index Key (CIK) for Immunocore Holdings plc is 1671927. Its filings are on SEC EDGAR. How many shares does Immunocore Holdings have outstanding? 51,498,617 shares as of 2026-07-31, per the cover page of its 10-Q filed 2026-08-06. Which country or territory is Immunocore Holdings listed under? Our directory records Immunocore Holdings plc under United Kingdom. What does Immunocore Holdings do? Our directory classifies Immunocore Holdings plc as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Immunocore Holdings? The ISIN recorded for Immunocore Holdings plc is US45258D1054. Does aibio.space cover Immunocore Holdings? aibio.space lists Immunocore Holdings plc among 2,820 public biotech companies and publishes its news here as stories appear. Where is Immunocore Holdings incorporated? SEC records list its state or country of incorporation as X0. Is Immunocore Holdings profitable? Immunocore Holdings plc reported a net loss of $35.5 million for the fiscal year ended Dec 31, 2025, and used $10.7 million of cash in operations, per its annual report to the SEC. How much does Immunocore Holdings spend on research and development? $274.9 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Immunocore Holdings have? $880.2 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. What is Immunocore Holdings's market cap? We do not publish live share prices. In its annual report, Immunocore Holdings plc put the market value of shares held by non-affiliates (public float) at $1.50 billion as of Jun 30, 2025. Is Immunocore Holdings a smaller reporting company? SEC records list Immunocore Holdings plc's filer category as: Large accelerated filer. Where is Immunocore Holdings headquartered? SEC records list its business address as 90 PARK DRIVE, OXFORDSHIRE, United Kingdom, OX14 4RY. ## Investor discussion: Immunocore Holdings Members talk about Immunocore Holdings (IMCR). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Immunocore Holdings, newest first. Each line links the filing it comes from. 1. 2025-03-17 Financings Reported a financing. SEC Form 424B7. [Source](https://www.sec.gov/Archives/edgar/data/1671927/000114036125008917/ny20045585x1_424b7.htm) 2. 2024-11-08 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02). [Source](https://www.sec.gov/Archives/edgar/data/1671927/000114036124045855/ef20038285_8k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:IMCR on TradingView](https://www.tradingview.com/symbols/NASDAQ-IMCR/). ## SEC filings and registration - **SEC name**: Immunocore Holdings plc - **CIK**: 1671927 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: IMCR (Nasdaq) - **State or country of incorporation**: X0 - **Fiscal year ends**: December 31 - **Filer category**: Large accelerated filer - **Business address**: 90 PARK DRIVE, OXFORDSHIRE, United Kingdom, OX14 4RY - **Phone**: 01235 5430281 - **Shares outstanding**: 51,498,617 as of 2026-07-31 (10-Q filed 2026-08-06) - **Former names**: Immunocore Ltd ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000026/imcr-20260914.htm) filed 2026-09-14 - [10-Q](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000022/imcr-20260630.htm) filed 2026-08-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000020/imcr-20260806.htm) filed 2026-08-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1671927/000114036126022984/ef20075013_form8k.htm) filed 2026-05-27 - [8-K](https://www.sec.gov/Archives/edgar/data/1671927/000114036126019205/ef20072537_8k.htm) filed 2026-05-06 - [10-Q](https://www.sec.gov/Archives/edgar/data/1671927/000167192726000009/imcr-20260331.htm) filed 2026-05-06 - [DEF 14A](https://www.sec.gov/Archives/edgar/data/1671927/000114036126015122/ny20070395x1_def14a.htm) filed 2026-04-16 - [8-K](https://www.sec.gov/Archives/edgar/data/1671927/000114036126006721/ef20066378_8k.htm) filed 2026-02-25 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001671927), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Immunocore Holdings plc is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IMCR, recorded under United Kingdom. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Immunocore Holdings plc - **Ticker**: IMCR - **Listing**: NASDAQ - **Country or territory**: United Kingdom - **Business scope**: Biotechnology - **ISIN**: US45258D1054 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-IMCR/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/immunocore/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Immunocore Holdings (IMCR) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/immunocore/